CytoDyn Announces Partial Clinical Hold of HIV Program and Full Clinical Hold of COVID-19 Program
Live webcast to be held March 31 discussing announcement VANCOUVER, Washington, March 30, 2022 (GLOBE…
Year: 2022
Aerovate Therapeutics Announces Full-Year 2021 Financial Results
Initiated IMPAHCT, a global Phase 2b/Phase 3 trial of AV-101 for pulmonary arterial hypertension (PAH)…
LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Phase 3 registrational trial of mavacamten in Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM)…
MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference
NEWS RELEASEMarch 30, 2022, 4:30 PM EST / 22:30 CET MDxHealth to Participate in the…
Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
– Completed dosing in older adults portion of Phase 1/1b clinical trial for IVX-121, a…
Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome
Strong rationale for development for Alport syndrome as ELOX-02 has demonstrated significant readthrough in COL4A5…
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2021 Results
FORT WORTH, TX, March 30, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort…
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
Twirla Demand Grows with Cycles Dispensed and Total Prescriptions (TRx) Up 35% and 33% Respectively…
RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Preliminary First Quarter 2022 UPNEEQ® Revenue Estimate and Business Update
Fourth quarter 2021 UPNEEQ product sales of $3.1 million, representing 39% growth over third quarter…
Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business Highlights
BDC-1001 for the treatment of patients with HER2-expressing solid tumors on track for recommended Phase…
Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
— Enrollment continues in Phase 2 JUNIPER trial of ANG-3070 for the treatment of patients…
Clarus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
2021 net revenue increased 119% year-over-year to $14.0 million Fourth quarter 2021 net revenue increased…
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
– Pipeline Includes Three New Chemical Entities with Clinical Proof-Of-Concept (POC) Following CRN04894 and CRN04777…
Crinetics Pharmaceuticals Reports Positive Top-Line Results from CRN04777 Phase 1 Study Multiple-Ascending Dose Cohorts
Results Further Support Clinical Proof-of-Concept for CRN04777 by Showing Dose-Dependent Decreases in Fasting and Sulfonylurea-Induced…
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
– Company strengthens strategic focus on rare disease and immuno-oncology assets and details expected upcoming…
LBank Exchange Will List Cryptounit (CRU) on March 30, 2022
Internet City, Dubai–(Newsfile Corp. – March 30, 2022) – LBank Exchange, a global digital asset…
Weimob (2013.HK) Smart Retail sends SaaS revenues soaring 90.9%
SHANGHAI, Mar 31, 2022 – (ACN Newswire) – Weimob Inc (2013.HK) released its 2021 financial…
IQVIA Selected to Support EMA’s DARWIN EU® Coordination Centre Initiative
AMSTERDAM–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research…
Appgate Announces Fourth Quarter and Full Year 2021 Financial Results
Fourth quarter revenue of $13.9 million, an increase of 36% year-over-year Annual recurring revenue (ARR)…
Siebert Reports Fourth Quarter and Full Year 2021 Financial Results
Revenue Growth of 23% for Full Year 2021 Operating Income Growth of 111% for Full…